- Home
- USEG vs ACRV Comparison
USEG vs ACRV Comparison
Compare USEG & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEG
- ACRV
- Stock Information
- Founded
- USEG 1966
- ACRV 2018
- Country
- USEG United States
- ACRV United States
- Employees
- USEG N/A
- ACRV N/A
- Industry
- USEG Oil & Gas Production
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- USEG Energy
- ACRV Health Care
- Exchange
- USEG Nasdaq
- ACRV Nasdaq
- Market Cap
- USEG 40.5M
- ACRV 47.8M
- IPO Year
- USEG N/A
- ACRV 2022
- Fundamental
- Price
- USEG $1.19
- ACRV $1.89
- Analyst Decision
- USEG Strong Buy
- ACRV Buy
- Analyst Count
- USEG 1
- ACRV 6
- Target Price
- USEG $3.50
- ACRV $17.75
- AVG Volume (30 Days)
- USEG 642.3K
- ACRV 430.6K
- Earning Date
- USEG 11-10-2025
- ACRV 11-12-2025
- Dividend Yield
- USEG N/A
- ACRV N/A
- EPS Growth
- USEG N/A
- ACRV N/A
- EPS
- USEG N/A
- ACRV N/A
- Revenue
- USEG $12,542,000.00
- ACRV N/A
- Revenue This Year
- USEG N/A
- ACRV N/A
- Revenue Next Year
- USEG $84.68
- ACRV $805.34
- P/E Ratio
- USEG N/A
- ACRV N/A
- Revenue Growth
- USEG N/A
- ACRV N/A
- 52 Week Low
- USEG $0.98
- ACRV $1.05
- 52 Week High
- USEG $6.40
- ACRV $8.74
- Technical
- Relative Strength Index (RSI)
- USEG 47.13
- ACRV 58.10
- Support Level
- USEG $1.17
- ACRV $1.96
- Resistance Level
- USEG $1.37
- ACRV $2.18
- Average True Range (ATR)
- USEG 0.06
- ACRV 0.15
- MACD
- USEG 0.00
- ACRV -0.00
- Stochastic Oscillator
- USEG 29.63
- ACRV 63.27
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.